Drug Prices
The AHA today urged the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program.
The AHA urges the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program.
Seventeen organizations, including the AHA, today urged Congress to resist any attempts from the pharmaceutical industry to undo during the lame duck session provisions included in the Bipartisan Budget Act to make prescription drugs more affordable for seniors.
On October 25, the Centers for Medicare & Medicaid Services issued an advance notice of proposed rulemaking to solicit public comments on potential options for testing a new model for paying for prescription drugs under Medicare Part B provided in physician offices, hospital outpatient…
The Centers for Medicare & Medicaid Services today issued an advance notice of proposed rulemaking seeking comments through Dec. 31 on potential options the agency may consider for testing changes to payment for certain separately payable Part B drugs and biologicals.
Rick Pollack
For the second time in less than a month, the Department of Justice has approved a megamerger between leading players in the health insurance and pharmacy worlds. The DOJ said it will allow the $69 billion merger of CVS Health with Aetna once the insurer sells its Medicare Part D business, which…
Also in this weekly roundup of health care news: Northwell Health takes cafeteria cues from a Michelin-starred chef; you may have diabetes and not know it; and a new public safety crisis across the country.
The House of Representatives yesterday passed two bills that would prohibit health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance.